Altogether, APP-CTFs—but more importantly CTFβ—emerges as an important pathogenic factor for AD and as a potential biomarker in cerebrospinal fluid of AD patients (García-Ayllón et al., 2017). The gene discussed is APP; the disease is Alzheimer disease.